FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RemedyRepack TraMADol HCl 50 mg Tablet Recall

TraMADol HCl 50 mg Tablet, Packaged as (a) 30-count blister pack

RemedyRepack Inc. · Indiana, PA

Risk level
Class II
Reported by FDA
May 15, 2024
Recall ID
D-0489-2024
Check your lot numberHow we source this data

Summary

RemedyRepack recalled TraMADol HCl 50 mg Tablet starting May 2, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0489-2024 on May 15, 2024. Reason: Presence of Foreign Tablets: Manufacturer received a report from a Pharmacist who reported finding a tablet of baclofen in a bottle of 1000-count tramadol. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets: Manufacturer received a report from a Pharmacist who reported finding a tablet of baclofen in a bottle of 1000-count tramadol

Product description

TraMADol HCl 50 mg Tablet, Packaged as (a) 30-count blister pack, NDC 70518-3824-00; (b) 90-count blister pack, NDC 70518-3824-02; (a) 180-count blister pack, NDC 70518-3824-03; RX ONLY, MFG: Advagen Pharma Limited, Plainsboro. NJ 08536, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 724.465.8762

Lot numbers, UPCs & expiration codes

Lots#: (a)J0732085-101023, Exp (b) B2546618-100523, Exp (c) B2546541-100523

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0489-2024
Classification
Class II
Status
Terminated
Recall initiated
May 2, 2024
FDA report date
May 15, 2024
Quantity
23,970 Tablets
Recall type
Voluntary: Firm initiated
Recalling firm
RemedyRepack Inc.

Original FDA data

Every field from FDA enforcement report D-0489-2024, exactly as published.

Show all FDA fields
City
Indiana
State
PA
Status
Terminated
Country
United States
Event ID
94567
Address
625 Kolter Dr Ste 4
Code information
Lots#: (a)J0732085-101023, Exp (b) B2546618-100523, Exp (c) B2546541-100523
Postal code
15701-3571
Report date
May 15, 2024
Product type
Drugs
Recall number
D-0489-2024
Classification
Class II
Recalling firm
RemedyRepack Inc.
Product quantity
23,970 Tablets
Termination date
Sep 9, 2024
Reason for recall
Presence of Foreign Tablets: Manufacturer received a report from a Pharmacist who reported finding a tablet of baclofen in a bottle of 1000-count tramadol
Voluntary / mandated
Voluntary: Firm initiated
Product description
TraMADol HCl 50 mg Tablet, Packaged as (a) 30-count blister pack, NDC 70518-3824-00; (b) 90-count blister pack, NDC 70518-3824-02; (a) 180-count blister pack, NDC 70518-3824-03; RX ONLY, MFG: Advagen Pharma Limited, Plainsboro. NJ 08536, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, 724.465.8762
Distribution pattern
Nationwide in the USA
Recall initiation date
May 2, 2024
Initial firm notification
E-Mail
Center classification date
May 8, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0489-2024, published May 15, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls